Hudson Technologies [HDSN] vs Ingevity [NGVT] Detailed Stock Comparison
Hudson Technologies
NASDAQ
Loading...
Ingevity
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Hudson Technologies wins in 8 metrics, Ingevity wins in 11 metrics, with 0 ties. Ingevity appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hudson Technologies | Ingevity | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.22 | 12.96 | Ingevity |
| Price-to-Book Ratio | 1.66 | 15.49 | Hudson Technologies |
| Debt-to-Equity Ratio | 2.34 | 1,139.77 | Hudson Technologies |
| PEG Ratio | 22.02 | 12.66 | Ingevity |
| EV/EBITDA | 13.09 | 8.07 | Ingevity |
| Profit Margin (TTM) | 8.08% | -16.35% | Hudson Technologies |
| Operating Margin (TTM) | 17.47% | 23.53% | Ingevity |
| EBITDA Margin (TTM) | 17.47% | 23.53% | Ingevity |
| Return on Equity | 7.22% | -106.83% | Hudson Technologies |
| Return on Assets (TTM) | 4.01% | 8.90% | Ingevity |
| Free Cash Flow (TTM) | $86.51M | $51.00M | Hudson Technologies |
| 1-Year Return | 21.93% | 45.12% | Ingevity |
| Price-to-Sales Ratio (TTM) | 1.88 | 1.41 | Ingevity |
| Enterprise Value | $344.81M | $3.17B | Ingevity |
| EV/Revenue Ratio | 1.53 | 2.39 | Hudson Technologies |
| Gross Profit Margin (TTM) | 31.31% | 37.77% | Ingevity |
| Revenue per Share (TTM) | $5 | $36 | Ingevity |
| Earnings per Share (Diluted) | $0.40 | $-5.95 | Hudson Technologies |
| Beta (Stock Volatility) | 0.96 | 1.37 | Hudson Technologies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hudson Technologies vs Ingevity Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hudson Technologies | 1.44% | -0.30% | 21.55% | 27.85% | 75.31% | 73.46% |
| Ingevity | 3.18% | 8.68% | 14.35% | 25.14% | 20.71% | 36.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hudson Technologies | 21.93% | -1.62% | 882.83% | 246.26% | 428.80% | 508.13% |
| Ingevity | 45.12% | -28.52% | -9.53% | 96.98% | 96.98% | 96.98% |
Performance & Financial Health Analysis: Hudson Technologies vs Ingevity
| Metric | HDSN | NGVT |
|---|---|---|
| Market Information | ||
| Market Cap | $423.15M | $1.87B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 794,170 | 414,870 |
| 90 Day Avg. Volume | 461,080 | 278,080 |
| Last Close | $9.87 | $53.86 |
| 52 Week Range | $5.11 - $10.06 | $28.49 - $54.11 |
| % from 52W High | -1.89% | -0.46% |
| All-Time High | $27.50 (Apr 10, 1995) | $120.41 (Feb 18, 2019) |
| % from All-Time High | -64.11% | -55.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.03% | -0.07% |
| Quarterly Earnings Growth | 0.06% | -0.07% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | -0.16% |
| Operating Margin (TTM) | 0.17% | 0.24% |
| Return on Equity (TTM) | 0.07% | -1.07% |
| Debt to Equity (MRQ) | 2.34 | 1,139.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.84 | $3.31 |
| Cash per Share (MRQ) | $1.93 | $2.11 |
| Operating Cash Flow (TTM) | $71.55M | $215.40M |
| Levered Free Cash Flow (TTM) | $62.57M | $345.16M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Hudson Technologies vs Ingevity
| Metric | HDSN | NGVT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.22 | 12.96 |
| Forward P/E | 22.02 | 12.66 |
| PEG Ratio | 22.02 | 12.66 |
| Price to Sales (TTM) | 1.88 | 1.41 |
| Price to Book (MRQ) | 1.66 | 15.49 |
| Market Capitalization | ||
| Market Capitalization | $423.15M | $1.87B |
| Enterprise Value | $344.81M | $3.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.53 | 2.39 |
| Enterprise to EBITDA | 13.09 | 8.07 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.37 |
| Book Value per Share (MRQ) | $5.84 | $3.31 |
Financial Statements Comparison: Hudson Technologies vs Ingevity
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HDSN | NGVT |
|---|---|---|
| Revenue/Sales | $55.34M | $284.00M |
| Cost of Goods Sold | $43.28M | $170.60M |
| Gross Profit | $12.07M | $113.40M |
| Research & Development | N/A | $7.70M |
| Operating Income (EBIT) | $3.08M | $62.60M |
| EBITDA | $4.67M | $83.20M |
| Pre-Tax Income | $3.65M | $26.80M |
| Income Tax | $893,000 | $6.30M |
| Net Income (Profit) | $2.76M | $20.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HDSN | NGVT |
|---|---|---|
| Cash & Equivalents | $81.05M | $71.50M |
| Total Current Assets | $201.34M | $530.00M |
| Total Current Liabilities | $52.39M | $264.60M |
| Long-Term Debt | $4.42M | $1.37B |
| Total Shareholders Equity | $246.82M | $234.60M |
| Retained Earnings | $137.37M | $592.50M |
| Property, Plant & Equipment | $52.25M | $45.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HDSN | NGVT |
|---|---|---|
| Operating Cash Flow | $13.98M | $32.70M |
| Capital Expenditures | $-1.41M | N/A |
| Free Cash Flow | $12.75M | $15.40M |
| Debt Repayment | N/A | $-100.30M |
| Common Stock Repurchase | $-1.83M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HDSN | NGVT |
|---|---|---|
| Shares Short | 1.55M | 1.21M |
| Short Ratio | 3.97 | 5.78 |
| Short % of Float | 0.04% | 0.05% |
| Average Daily Volume (10 Day) | 794,170 | 414,870 |
| Average Daily Volume (90 Day) | 461,080 | 278,080 |
| Shares Outstanding | 44.28M | 36.35M |
| Float Shares | 35.57M | 36.19M |
| % Held by Insiders | 0.12% | 0.01% |
| % Held by Institutions | 0.83% | 1.03% |
Dividend Analysis & Yield Comparison: Hudson Technologies vs Ingevity
| Metric | HDSN | NGVT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |